Safety and efficacy of sofosbuvir‐based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta‐analysis

WHAT IS KNOWN AND OBJECTIVE: Sofosbuvir (SOF) is a new and highly effective medication that dramatically improved hepatitis C virus (HCV) management. However, ribavirin (RBV) is still added to SOF‐based medication regimens in several clinical scenarios, despite its well‐known toxicities. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshafie, Shaimaa, Trivedi‐Kapoor, Rupal, Ebell, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545628/
https://www.ncbi.nlm.nih.gov/pubmed/35678040
http://dx.doi.org/10.1111/jcpt.13698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545628/
https://www.ncbi.nlm.nih.gov/pubmed/35678040
http://dx.doi.org/10.1111/jcpt.13698

Ejemplares similares